Patient |
Prevention |
Gender |
Age |
Co-morbidities |
BMI |
Number of leads via
the cephalic |
ICD lead access |
LVEF (%) |
ICD lead |
Coils |
Implant procedure duration
(mins) |
Time to lead failure (years) |
1 |
Secondary |
M |
79 |
AF, HTN |
30 |
3 |
Cephalic |
28 |
Sprint
Fidelis |
Dual |
155 |
2.1 |
2 |
Secondary |
M |
70 |
IHD, HTN, IBD |
22 |
2 |
Cephalic |
25 |
Sprint
Quattro 6947 |
Dual |
309 |
0.1 |
3 |
Secondary |
F |
52 |
IHD, DM, RA, Asthma, HTN |
35 |
3 |
Cephalic |
20 |
Linox SD65 |
Dual |
81 |
5.8 |
4 |
Secondary |
F |
63 |
DCM, HTN |
36 |
3 |
Cephalic |
25 |
Sprint
Quattro 6935 |
Single |
122 |
4.4 |
5 |
Primary |
F |
71 |
IHD, HTN, COPD |
29 |
3 |
Cephalic |
30 |
Sprint
Quattro 6935 |
Single |
172 |
0.1 |
6 |
Primary |
F |
46 |
IHD, IBD |
48 |
3 |
Cephalic |
25 |
Endotak
Reliance 0181 |
Single |
54 |
5.0 |
7 |
Primary |
M |
75 |
DCM, HTN, AF |
30 |
3 |
Cephalic |
35 |
Endotak
Reliance 0181 |
Single |
85 |
3.3 |
8 |
Primary |
M |
73 |
DCM, HTN |
27 |
3 |
Cephalic |
20 |
Sprint
Quattro 6947 |
Dual |
69 |
4.6 |
9 |
Primary |
F |
64 |
IHD, HTN, |
26 |
0 |
Non-cephalic |
30 |
Vigila
2CR |
Dual |
210 |
7.6 |
10 |
Primary |
M |
62 |
IHD, HTN, AF, DM |
33 |
3 |
Cephalic |
23 |
Vigila 1CR |
Single |
135 |
6.4 |